Interviews

What can we help you find?
Dosing Patients with Kidney Disease Presents Unique Challenges
In an interview with Pharmacy Times, Bruce Mueller, PharmD, interim dean and professor of clinical pharmacy at the University of Michigan College of Pharmacy, said pharmacists are essential in providing the correct dosing to patients with kidney disease.
 
What the Potential Elimination of the Biologics Price Competition and Innovation Act Means for Pharmacy
Pharmacy Times® interviewed Chad Landmon, JD, of Axinn, Veltrop & Harkrider, on the arguments presented to the Supreme Court on whether a legislative change to the Affordable Care Act makes the law unconstitutional.
Involving Pharmacists in Clinical Decision-Making Is Essential
In an interview with Pharmacy Times, Peter Bonis, MD, said pharmacists are instrumental in making sure that patients receive drugs that are both safe and effective. 
The Importance of Formulary Adherence in Health Systems
In an interview with Pharmacy Times, Peter Bonis, MD, chief medical officer of clinical effectiveness at Wolters Kluwer Health, said formulary adherence in health systems is essential for several reasons. 
Strategies for Encouraging Collaboration in Clinical Decision Making
In an interview with Pharmacy Times, Peter Bonis, MD, chief medical officer of clinical effectiveness at Wolters Kluwer Health, said collaboration between pharmacists, physicians, and other health care workers is essential.
Predictability Around Shutdowns is Critical for Community Pharmacies During the Pandemic
Pharmacy Times® interviewed Maryland Secretary of Commerce Kelly M. Schulz on the economic impact of the COVID-19 pandemic on small businesses, such as community pharmacies.
Pediatricians Express Concerns About HHS Authorization of Pharmacists to Deliver Childhood Vaccines
In a discussion with Pharmacy Times, Susan DiGregorio, BS Pharm, MS, RPh, director of clinical pharmacy development at Community Care Rx, said that collaborating with pediatricians and other health care providers is essential for pharmacists to effectively administer vaccines to children.
 
More Than 500 Therapeutics Being Investigated for COVID-19
Pharmacy Times spoke with Michael Haydock, senior director of content for cardiovascular, metabolic, and infectious diseases at Informa Pharma Intelligence, about investigational therapeutics for COVID-19 and what’s in the pipeline.
 
COVID-19 Has Changed Consumer Behavior Trends for Prescription Fulfillment
Pharmacy Times® interviewed Amanda Epp, MBA, CEO of ScriptDrop, on how the COVID-19 pandemic has affected consumer behavior trends in the switch to digital prescription fulfillment.
The Work of the COVID-19 and Cancer Consortium During the COVID-19 Pandemic
Pharmacy Times® interviewed Petros Grivas, MD, PhD, associate professor at the University of Washington and Fred Hutchinson Cancer Research Center and a medical oncologist at Seattle Cancer Care Alliance, on the work of the COVID-19 and Cancer Consortium.
How Using Social Determinants of Health in Tandem With Clinical Data Can Benefit Pharmacies
Pharmacy Times® interviewed Rich Morino, senior director of health care solutions at LexisNexis, on how using social determinants of health in tandem with clinical data can benefit pharmacies.
Granting Pharmacists Provider Status Will Help in the Fight Against COVID-19
Pharmacy Times® interviewed Amanda Epp, MBA, the CEO of ScriptDrop, on how granting provider status to pharmacists can allow them to better support the health care system in the fight against COVID-19.